Prostaglandin F2alpha stimulates 11Beta-hydroxysteroid dehydrogenase 1 enzyme bioactivity and protein expression in bovine endometrial stromal cells

Biology of Reproduction

Volumn 80, Issue 4, 2009, Pages 657-664

  Lee, Hwa Yong ^a   Acosta, Tomas J ^a   Skarzynski, Dariusz J ^b   Okuda, Kiyoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

Cattle; Cortisol; Endometrium; HSD11B1; Prostaglandins; Uterus

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTISONE; HYDROCORTISONE; PROSTAGLANDIN F2 ALPHA;

ANIMAL TISSUE; ARTICLE; COW; ENDOMETRIUM CELL; ENZYME ACTIVITY; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; STROMA CELL;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; CATTLE; CELLS, CULTURED; DINOPROST; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INDOMETHACIN; STROMAL CELLS; TIME FACTORS; TOCOLYTIC AGENTS;

BOS; BOVINAE;

EID: 65249132983     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.108.073403     Document Type: Article

References (49)

1. Brann DW, Mahesh VB. Role of corticosteroids in female reproduction. FASEB J 1991; 5:2691-2698.
2. Andersen CY. Possible new mechanism of Cortisol action in female reproductive organs: physiological implications of the free hormone hypothesis. J Endocrinol 2002; 173:211-217.
3. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 1996; 17:245-261.
4. Stewart PM, Mason JI. Cortisol to cortisone: glucocorticoid to mineralocorticoid. Steroids 1995; 60:143-146.
5. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 1994; 105:11-17.
6. Stewart PM, Murry BA, Mason JI. Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues. J Clin Endocrinol Metab 1994; 78:1529-1532.
7. Lee HY, Acosta TJ, Tanikawa M, Sakumoto R, Komiyama J, Tasaki Y, Piskula M, Skarzynski DJ, Tetsuka M, Okuda K. The role of glucocorticoid in the regulation of prostaglandin biosynthesis in non- pregnant bovine endometrium. J Endocrinol 2007; 193:127-135.
8. Miyamoto Y, Skarzynski DJ, Okuda K. Is tumor necrosis factor a a trigger for the initiation of endometrial prostaglandin F2a release at luteolysis in cattle? Biol Reprod 2000; 62:1109-1115.
9. Murakami S, Miyamoto Y, Skarzynski DJ, Okuda K. Effects of tumor necrosis factor-α on secretion of prostaglandins E2 and F2α in bovine endometrium throughout the estrous cycle. Theriogenology 2001; 55: 1667-1678.
10. Poyser NL. The control of prostaglandin production by the endometrium in relation to luteolysis and menstruation. Prostaglandins Leukot Essent Fatty Acids 1995; 53:147-195.
11. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. Cyclooxygenase in biology and disease. FASEB J 1998; 12:1063-1073.
12. Alfaidy N, Xiong ZG, Myatt L, Lye SJ, MacDonald JF, Challis JR. Prostaglandin F2α potentiates cortisol production by stimulating 11 β - hydroxysteroid dehydrogenase 1: a novel feedback loop that may
13. contribute to human labor. J Clin Endocrinol Metab 2001; 86:5585-5592.
14. Alfaidy N, Li W, MacIntosh T, Yang K, Challis J. Late gestation increase in 11 β -hydroxysteroid dehydrogenase 1 expression in human fetal membranes: a novel intrauterine source of cortisol. J Clin Endocrinol Metab 2003; 88:5033-5038.
15. Whittle WL, Patel FA, Alfaidy N, Holloway AC, Fraser M, Gyomorey S,
16. Lye SJ, Gibb W, Challis JR. Glucocorticoid regulation of human and ovine parturition: the relationship between fetal hypothalamic-pituitary- adrenal axis activation and intrauterine prostaglandin production. Biol Reprod 2001; 64:1019-1032.
17. Patel FA, Sun K, Challis JR. Local modulation by 11 β -hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydrox- yprostaglandin dehydrogenase in human chorion and placental trophoblast cells. J Clin Endocrinol Metab 1999; 84:395-400.
18. Gibb W, Lavoie JC. Effects of glucocorticoids on prostaglandin formation by human amnion. Can J Physiol Pharmacol 1990; 68:671-676.
19. Fegan KS, Rae MT, Critchley HO, Hillier SG. Anti-inflammatory steroid signalling in the human peritoneum. J Endocrinol 2008; 196:369-376.
20. Willman EA, Collins WP. Distribution of prostaglandins E2 and F2α within the foetoplacental unit throughout human pregnancy. J Endocrinol 1976; 69:413-419.
21. Bah MM, Acosta TJ, Pilawski W, Deptula K, Okuda K, Skarzynski DJ. Role of intraluteal prostaglandin F2α, progesterone and oxytocin in basal and pulsatile progesterone release from developing bovine corpus luteum. Prostaglandins Other Lipid Mediat 2006; 79:218-229.
22. Skarzynski DJ, Miyamoto Y, Okuda K. Production of prostaglandin F2α by cultured bovine endometrial cells in response to tumor necrosis factor a: cell type specificity and intracellular mechanisms. Biol Reprod 2000; 62:1116-1120.
23. Fortier MA, Guilbault LA, Grasso F. Specific properties of epithelial and stromal cells from the endometrium of cows. J Reprod Fertil 1988; 83: 239-248.
24. Malayer JR, Woods VM. Expression of estrogen receptor and maintenance of hormone-responsive phenotype in bovine fetal uterine cells. Domest Anim Endocrinol 1998; 15:141-154.
25. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Biochemistry 1980; 102:344-352.
26. Battersby S, Boddy SC, Critchley HO, Jabbour HN. Expression and localization of endothelial monocyte-activating polypeptide II in the human endometrium across the menstrual cycle: regulation of expression by prostaglandin E (2). J Clin Endocrinol Metab 2002; 87:3928-3935.
27. Newton R, Kuitert LM, Slater DM, Adcock IM, Barnes PJ. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci 1997; 60: 67-78.
28. Wang B, Xiao C, Goff AK. Progesterone-modulated induction of apoptosis by interferon-Τ in cultured epithelial cells of bovine endometrium. Biol Reprod 2003; 68:673-679.
29. Sakumoto R, Komatsu T, Kasuya E, Saito T, Okuda K. Expression of mRNAs for interleukin-4, interleukin-6 and their receptors in porcine corpus luteum during the estrous cycle. Domest Anim Endocrinol 2006; 31:246-257.
30. Osnes T, Sandstad O, Skar V, Osnes M, Kierulf P. Total protein in common duct bile measured by acetonitrile precipitation and a micro bicinchoninic acid (BCA) method. Scand J Clin Lab Invest 1993; 53:757-763.
31. Sun K, Ma R, Cui X, Campos B, Webster R, Brockman D, Myatt L. Glucocorticoids induce cytosolic phospholipase A2 and prostaglandin H synthase type 2 but not microsomal prostaglandin E synthase (PGES) and cytosolic PGES expression in cultured primary human amnion cells. J Clin Endocrinol Metab 2003; 88:5564-5571.
32. Mirazi N, Alfaidy N, Martin R, Challis JR. Effects of dexamethasone and sulfasalazine on prostaglandin E2 output by human placental cells in vitro. J Soc Gynecol Invest 2004; 11:22-26.
33. Zhang Q, Collins V, Chakrabarty K, Wolf RF, Unno N, Howe D, Rose JC, Wu WX. Regulation of membrane-associated prostaglandin E2 synthase 1 in pregnant sheep intrauterine tissues by glucocorticoid and estradiol. Endocrinology 2006; 147:3719-3726.
34. Asselin E, Drolet P, Fortier MA. Cellular mechanisms involved during oxytocin-induced prostaglandin F2α production in endometrial epithelial cells in vitro: role of cyclooxygenase-2. Endocrinology 1997; 138:4798-4805.
35. Kelly RW. Inflammatory mediators and parturition. Rev Reprod 1996; 1: 89-96.
36. Kindahl H, Odensvik K, Aiumlamai S, Fredriksson G. Utero-ovarian relationships during the bovine postpartum period. Anim Reprod Sci 1992; 28:363-369.
37. Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981; 88:434-442.
38. Adams GP, Kastelic JP, Bergfelt DR, Ginther OJ. Effect of uterine inflammation and ultrasonically-detected uterine pathology on fertility in the mare. J Reprod Fertil Suppl 1987; 35:445-454.
39. Hardy DB, Pereira LE, Yang K. Prostaglandins and leukotriene B4 are potent inhibitors of 11 β -hydroxysteroid dehydrogenase type 2 activity in human choriocarcinoma JEG-3 cells. Biol Reprod 1999; 61:40-45.
40. Frey BM, Walker C, Frey FJ, de Weck AL. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol 1984; 133:2479-2487.
41. Knudsen PJ, Dinarello CA, Strom TB. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 1987; 139:4129-4134.
42. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I kappa B α in mediation of immunosuppression by glucocorticoids. Science 1995; 270:283-286.
43. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immuno- suppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270:286-290.
44. Pakrasi PL, Cheng HC, Dey SK. Prostaglandins in the uterus: modulation by steroid hormones. Prostaglandins 1983; 26:991-1009.
45. Escher G, Galli I, Vishwanath BS, Frey BM, Frey FJ. Tumor necrosis factor α and interleukin 1 β enhance the cortisone/cortisol shuttle. J Exp Med 1997; 186:189-198.
46. Jonas KC, Chandras C, Abayasekara DR, Michael AE. Role for prostaglandins in the regulation of type 1 11 β -hydroxysteroid dehydrogenase in human granulosa-lutein cells. Endocrinology 2006; 147:5865-5872.
47. Pretorius E, Wallner B, Marx J. Cortisol resistance in conditions such as asthma and the involvement of 11 β -HSD-2: a hypothesis. Horm Metab Res 2006; 38:368-376.
48. Chatterjee A, Jana NR, Bhattacharya S. Stimulation of cyclic AMP, 17β oestradiol and protein synthesis by human chorionic gonadotrophin in human endometrial cells. Hum Reprod 1997; 12:1903-1908.
49. Zhang W, Zhang Y, Edvinsson L, Xu CB. Up-regulation of thromboxane A (2) receptor expression by lipid soluble smoking particles through post- transcriptional mechanisms. Atherosclerosis 2007; 196:608-616.